Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma,Journal of Clinical Oncology

当前位置： X-MOL 学术 › J. Clin. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma
Journal of Clinical Oncology ( IF 45.3 ) Pub Date : 2023 , DOI: 10.1200/jco.23.00562
Michael L Wang ₁ , Wojciech Jurczak ₂ , Pier Luigi Zinzani _{3,

4} , Toby A Eyre ₅ , Chan Y Cheah _{6,

7} , Chaitra S Ujjani ₈ , Youngil Koh ₉ , Koji Izutsu ₁₀ , James N Gerson ₁₁ , Ian Flinn ₁₂ , Benoit Tessoulin ₁₃ , Alvaro J Alencar ₁₄ , Shuo Ma ₁₅ , David Lewis ₁₆ , Ewa Lech-Maranda ₁₇ , Joanna Rhodes _{18,

19} , Krish Patel ₂₀ , Kami Maddocks ₂₁ , Nicole Lamanna ₂₂ , Yucai Wang ₂₃ , Constantine S Tam ₂₄ , Talha Munir ₂₅ , Hirokazu Nagai ₂₆ , Francisco Hernandez-Ilizaliturri ₂₇ , Anita Kumar ₂₈ , Timothy S Fenske ₂₉ , John F Seymour ₂₄ , Andrew D Zelenetz ₂₈ , Binoj Nair ₃₀ , Donald E Tsai ₃₀ , Minna Balbas ₃₀ , Richard A Walgren ₃₀ , Paolo Abada ₃₀ , Chunxiao Wang ₃₁ , Junjie Zhao ₃₀ , Anthony R Mato ₂₈ , Nirav N Shah ₂₉

Affiliation

MD Anderson Cancer Center, Houston, TX.
Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.
IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli," Bologna, Italy.
Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy.
Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom.
Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WA, Australia.
Medical School, University of Western Australia, Perth, WA, Australia.
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
Seoul National University Hospital, Seoul, Korea.
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
University of Vermont, Burlington, VT.
Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.
Haematology Department, University Hospital, Nantes, France.
Sylvester Comprehensive Cancer Center, Miami, FL.
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
Plymouth Hospitals NHS Trust-Derriford Hospital, Plymouth, United Kingdom.
Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Uniondale, NY.
Northwell Health Cancer Institute Lake Success, New Hyde Park, NY.
Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY.
Division of Hematology, Mayo Clinic, Rochester, MN.
Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia.
Department of Haematology, St James's University Hospital, Leeds, United Kingdom.
Department of Hematology, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Memorial Sloan Kettering Cancer Center, New York, NY.
Medical College of Wisconsin, Milwaukee, WI.
Indianapolis, IN.
Eli Lilly and Company, Indianapolis, IN.